zostavax [ zoster vaccine live (oka/merck), msd]
merck sharp & dohme (malaysia) sdn bhd - zoster vaccine live oka/merck -
zostavax (zoster vaccine live)
merck sharp & dohme (israel - 1996) company ltd, israel - live attenuated oka/merck strain of varicella-zoster virus - powder and solvent for suspension for injection - live attenuated oka/merck strain of varicella-zoster virus 19400 pfu / 0.65 ml - zoster, live attenuated - zoster, live attenuated - zostavax is a live attenuated virus vaccine indicated for prevention of herpes zoster (shingles) in individuals 50 years of age and older.
zostavax- zoster vaccine live injection, powder, lyophilized, for suspension sterile diluent- sterile water injection
merck sharp & dohme llc - varicella-zoster virus strain oka/merck live antigen (unii: gpv39zgd8c) (varicella-zoster virus strain oka/merck live antigen - unii:gpv39zgd8c) - varicella-zoster virus strain oka/merck live antigen 19400 [pfu] in 0.65 ml - zostavax® is a live attenuated virus vaccine indicated for prevention of herpes zoster (shingles) in individuals 50 years of age and older. limitations of use of zostavax: - zostavax is not indicated for the treatment of zoster or postherpetic neuralgia (phn). - zostavax is not indicated for prevention of primary varicella infection (chickenpox). do not administer zostavax to individuals with a history of anaphylactic/anaphylactoid reaction to gelatin, neomycin or any other component of the vaccine. neomycin allergy manifested as contact dermatitis is not a contraindication to receiving this vaccine. {1} do not administer zostavax to individuals who are immunodeficient or immunosuppressed due to disease or therapy, as serious or fatal disseminated vaccine strain varicella-zoster virus disease may occur. causes of immunodeficiency or immunosuppression may include, but are not limited to, primary or acquired immunodeficiency states, aids or other clinical manifestations of infection with human immunodeficiency
varivax- varicella virus vaccine live injection, powder, lyophilized, for suspension
merck sharp & dohme llc - varicella-zoster virus strain oka/merck live antigen (unii: gpv39zgd8c) (varicella-zoster virus strain oka/merck live antigen - unii:gpv39zgd8c) - varicella-zoster virus strain oka/merck live antigen 1350 [pfu] in 0.5 ml - varivax is a vaccine indicated for active immunization for the prevention of varicella in individuals 12 months of age and older. do not administer varivax to individuals with a history of anaphylactic or severe allergic reaction to any component of the vaccine (including neomycin and gelatin) or to a previous dose of a varicella-containing vaccine. do not administer varivax to individuals who are immunodeficient or immunosuppressed due to disease or medical therapy. disseminated varicella disease and extensive vaccine-associated rash have been reported in individuals who are immunosuppressed or immunodeficient who were inadvertently vaccinated with a varicella-containing vaccine. do not administer varivax to individuals with an active febrile illness with fever >101.3°f (>38.5°c). do not administer varivax to individuals with active, untreated tuberculosis (tb). do not administer varivax to individuals who are pregnant or planning on becoming pregnant in the next 3 months. wild-type varicella is known to cau
zostavax
merck sharp & dohme b.v. - varicella-zoster virus (live, attenuated) - herpes zoster; immunization - viral vaccines - zostavax is indicated for prevention of herpes zoster ('zoster' or shingles) and herpes-zoster-related post-herpetic neuralgia. zostavax is indicated for immunisation of individuals 50 years of age or older.,
zostavax
merck sharp & dohme (new zealand) limited - varicella-zoster virus, oka/merck strain, live, attenuated 19400 pfu; - injection with diluent - 19400 pfu - active: varicella-zoster virus, oka/merck strain, live, attenuated 19400 pfu excipient: dibasic sodium phosphate monohydrate gelatin monobasic potassium phosphate monosodium glutamate potassium chloride sodium chloride sucrose urea water for injection - zostavax is indicated for: · prevention of herpes zoster (shingles)
zostavax vaccine powder and solvent for suspension for injection 0.65ml pre-filled syringes
merck sharp & dohme ltd - varicella-zoster virus live attenuated (oka/merck strain) - powder and solvent for suspension for injection
varivax vaccine powder and solvent for suspension for injection 0.5ml vials
merck sharp & dohme (uk) ltd - varicella-zoster virus live attenuated (oka/merck strain) - powder and solvent for suspension for injection
zostavax powder for suspension
merck canada inc - varicella-zoster virus vaccine live attenuated (oka/merck strain) - powder for suspension - 19400pfu - varicella-zoster virus vaccine live attenuated (oka/merck strain) 19400pfu - vaccines
zostavax ii powder for suspension
merck canada inc - varicella-zoster virus vaccine live attenuated (oka/merck strain) - powder for suspension - 19400pfu - varicella-zoster virus vaccine live attenuated (oka/merck strain) 19400pfu - vaccines